Skip to main content
. 2018 Jan 17;8:948. doi: 10.1038/s41598-017-18900-y

Figure 1.

Figure 1

(A) Response of cells to sorafenib detected by MTS assay. The average of three independent experiments and SD are shown. (B) Representative Western blot analysis reporting the expression and the phosphorylation of different proteins belonging to the MAPK and PI3K pathways in the KRAS-expressing clones treated with sorafenib 1 uM, at the indicated time points.